// App-Quantinova.ai

Mo1248 : RECURRENCE OF GASTRO-ESOPHAGEAL JUNCTION INTESTINAL METAPLASIA AFTER ENDOSCOPIC ERADICATION OF BARRETT'S ESOPHAGUS IS NOT ASSOCIATED WITH INCREASED RATES OF DYSPLASIA RECURRENCE: RESULTS OF A MULTI-CENTER COHORT STUDY

Researchers

Presenter

  • Quinn Solfisburg

Principal Investigators

  • Sami S. Sarmed

  • Joel Gabre

  • Ali Soroush

  • Lovekirat Dhaliwal

  • John M. Poneros

  • Gary W. Falk

  • Gregory G. Ginsberg

  • Kenneth K. Wang

  • Charles J. Lightdale

  • Prasad G. Iyer

  • Julian A. Abrams

Medical Centers

  • University College London Hospitals NHS Trust, London, United Kingdom

  • University of Pennsylvania Perelman School of Medicine, Philadelphia, PA

  • Columbia University Medical Center, New York, NY

  • Mayo Clinic, Rochester, Rochester, MN

Locations

  • United Kingdom

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Gastroenterology (GU)

Disease

  • Barrett's esophagus

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • Multicenteric

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A